Motor Carrier Safety Program

1 Revised 1-8-2016 GlaxoSmithKline Motor Carrier Safety Program Revised 1-8-2016 CONTENTS Driver Safety Purpose ..2 Driver Pre- employment Requirements to Operate a Commercial Motor Vehicle ..5 Controlled Substance and Alcohol Use and Testing ..6 Commercial Driver s License Standards; Requirements and Penalties ..7 Federal Motor Carrier Safety Regulations General ..8 Qualifications of Drivers ..8 Suspended, Restricted or Revoked Driver s License ..8 Driving Record Acceptability Criteria ..8 Driving of Commercial Motor Vehicles ..10 Use of Cell Phone While Driving ..13 Commercial Motor Vehicle Maintenance ..14 Hours of Service ..15 What Should You Do In Case Of an Accident ..16 Accident Reporting Requirements ..17 Incidents and/or Accidents Involving Hazardous Materials ..19 Accident Report ..20 Accident Review Board ..21 Vehicle Accident Review Process ..21 Penalty Assessment For Significant Safety Infractions ..22 Acknowledgement and Compliance Agreement.

2 23 Revised 1-8-2016 GLAXOSMITHKLINE Motor Carrier Safety Program GlaxoSmithKline is committed to safe transportation and compliance with the applicable regulations of the Department of Transportation and state and local transportation departments. In order to ensure compliance, GlaxoSmithKline has instituted a Motor Carrier Safety Program that implements the Federal Motor Carrier Safety Regulations (FMCSRs), the Federal Hazardous Materials Regulations (HMRs), applicable state and local transportation requirements. This Program assures that Motor vehicles used to transport GlaxoSmithKline materials are properly inspected and maintained, and is designed to address specific issues concerning the operation of: (1) commercial Motor vehicles weighing 10,001 pounds or more; (2) commercial Motor vehicles utilized to transport any amount of hazardous materials; (3) Motor vehicles utilized to transport passengers; and (4) all drivers of these Motor vehicles. They receive initial and recurrent training as required by the FMCSR s and HMR s, or as needed.

3 The training is provided by qualified company officials and Safety professionals. The training includes federal and state regulatory requirements that pertain to the operation of commercial Motor vehicles and the drivers, and the transportation of hazardous materials. Training also includes all applicable company policies. This Safety training is reinforced through regularly scheduled Safety meetings that address new requirements and compliance areas that warrant additional attention. All drivers and driver supervisors or any other persons appointed over drivers must comply with the requirements set forth in Title 49 CFR Parts 40, 325, and 355-399(FMCSR), Title 49 CFR Parts 106-180(HMR), all applicable state regulations, and all GlaxoSmithKline policies. It is GlaxoSmithKline s intention to comply fully with the DOT regulations governing commercial Motor vehicles and the drivers that drive them. In the event the DOT regulations are amended, this policy and the applicable terms, conditions, and or requirements of this policy shall be deemed to have been amended automatically at that time without the need for redrafting, in order to reflect and be in compliance with DOT regulations.

4 In such case, GlaxoSmithKline reserves the right to apply amended requirements immediately and without giving prior notice to drivers and/or applicants or other employees covered by this policy, unless such notice is required by the DOT or other applicable law. This policy shall not apply to the extent it is inconsistent with the requirements of any state or local law. All drivers, supervisors and managers will be made aware of the Compliance, Safety , and Accountability (CSA) Program that is administered by the Federal Motor Carrier Safety Administration (FMCSA). This Program will assess points to drivers as well as GSK to determine if any action is needed on the part of the FMCSA, up to and including an onsite audit. There are four major elements to CSA 1-measurement, 2-intervention, 3- Safety evaluation, and information technology - 4-COMPASS. Revised 1-8-2016 1)- The measurement system would group the Safety performance data of Motor carriers and drivers into seven categories, called BASICs Behavioral Analysis Safety Improvement Categories.

5 The seven BASICs are: (1) Unsafe Driving, (2) Fatigued Driving, (3) Driver Fitness, (4) Controlled Substances/Alcohol, (5) Vehicle Maintenance, (6) Improper Loading/Cargo, and (7) Crash Indicator. 2)- Intervention Once the measurement system signals the need to intervene, CSA 2010 would draw upon a broad array of progressive interventions that are designed to advise the Motor Carrier or driver that their Safety performance has come to the government s attention. These steps are meant to improve unsafe behavior early. These include: Warning Letter Targeted Roadside Inspection Off-Site Investigation On-Site Investigation - Focused Cooperative Safety Plan Notice of Violation Increasing Severity On-Site Investigation - Comprehensive Notice of Claim/Settlement Agreement 3)- Safety Evaluation Safety fitness determination would be based on performance data processed through the measurement system, and would not necessarily be tied to the current FMCSA compliance review.

6 Depending on the Motor Carrier s BASIC scores, the Safety fitness determination could be continue to operate, marginal (with ongoing intervention), or proposed unfit. Each Motor Carrier or driver for which there is sufficient data would receive a Safety fitness determination that would be updated every 30 days. 4)- CSA is an FMCSA-wide initiative that is leveraging new technology to transform the way that FMCSA does business. By optimizing FMCSA business processes and improving the Agency s IT functionality, it will help FMCSA and State enforcement personnel make better decisions, identify high-risk carriers and drivers more effectively, and apply a wider range of interventions to correct high-risk behavior early. Revised 1-8-2016 Under the Compliance, Safety , Accountability (CSA) Program , the FMCSA has provided Motor carriers and enforcement officials with the Safety Management Cycle. Investigators will be using this model to determine where a Carrier is having trouble with its Safety management controls, if there is a problem.

7 Listed below are the areas of the Safety Management Cycle: 1. Policies and Procedures 2. Roles and Responsibilities 3. Qualification and hiring 4. Training and Communication 5. Monitoring and Tracking 6. Meaningful Action (proactive measures) Using the Safety Management Cycle, FMCSA investigators will be looking directly at Safety management controls. This means they will be looking at what management does to ensure compliance. As a result, driver supervisors who know a driver or drivers is non-compliant may be subject to disciplinary action. Driver Pre- employment Requirements to Operate a Commercial Motor Vehicle (Anyone transferring to a driving position must meet the same requirements as pre- employment drivers) Prior to driving a commercial Motor vehicle for, or on behalf of GSK, all applicants weather employee or contractor must meet the following requirements. 1. Have a completed Driver Qualification file. 2. Posses a valid driver s license or CDL if required, with applicable endorsements.

8 3. Posses a valid Medical Examiner s certificate. 4. Successfully complete a road test. 5. Complete MVR ( Motor Vehicle Record) process to have their driving record checked. All drivers must submit to MVR screening and will not be authorized to drive any GSK owned or a leased vehicle until their MVR has been returned to GSK for review. Any driver failing to complete the bi-annual MVR process will be removed as an authorized driver. If a driver is removed for failure to complete the MVR process, they may not be re-instated as an authorized driver until the following MVR campaign. 6. Complete a pre- employment drug test (if applicable). 7. Receive training or be scheduled to receive training on the FMCSR s within 30 days. a. Entry level drivers will receive additional training at this time. b. Training in the OmniVision system will be completed at this time. c. CSA training will be completed at this time. 8. Receive training or be scheduled to receive training on alcohol and drug abuse within 30 days.

9 9. Be added to the random Drug and Alcohol Program (if applicable). Contract workers may complete item number one and item number six listed above by having their company provide a copy of the completed Driver Qualification file, and a separate letter Revised 1-8-2016 stating that the driver was pre- employment drug tested. All contractors that drive commercial Motor vehicles must have the letter in their file prior to operating any GSK owned or leased vehicles on behalf of GSK. Controlled Substance and Alcohol Use and Testing The purpose of this is to prevent accidents and injuries resulting from the misuse of alcohol or use of controlled substances by drivers of commercial Motor vehicles. This part applies to all employees/contractors who operate a commercial Motor vehicle in commerce in any state or province and is subject to: 1. The commercial driver s license requirements of 49 CFR Part 383; 2. The commercial driver s license requirements of the Canadian National Safety Code.

10 All commercial Motor vehicle drivers will receive a copy of GSK s Alcohol and Drug Use policy as well as the GlaxoSmithKline Motor Carrier Safety Program Drug and Alcohol Policy. Violations of either of these company policies may result in disciplinary action. All contractors that are subject to Random Drug & Alcohol testing must also have in their file a letter from their company stating that they are in a random drug & alcohol testing pool in compliance with 49 CFR Part 382. This letter must be updated annually or as needed. 1. Some states require that the employing Motor Carrier notify the state DMV office if a driver has positive results on a drug or alcohol test. Revised 1-8-2016 Commercial Driver s License Standards; Requirements and Penalties The purpose of this part is to establish who is required to possess a Commercial Driver s License (CDL), and to reduce and/or prevent accidents and injuries by requiring drivers to have a single commercial Motor vehicle driver s license, and by disqualifying drivers who operate commercial Motor vehicles in an unsafe manner.